Authors:
Zhao, X
Demary, K
Wong, L
Vaziri, C
McKenzie, AB
Eberlein, TJ
Spanjaard, RA
Citation: X. Zhao et al., Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN), CELL DEAT D, 8(9), 2001, pp. 878-886
Authors:
Joo, HG
Goedegebuure, PS
Sadanaga, N
Nagoshi, M
von Bernstorff, W
Eberlein, TJ
Citation: Hg. Joo et al., Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes, J LEUK BIOL, 69(4), 2001, pp. 555-564
Authors:
Lockhart, DC
Chan, AK
Mak, S
Joo, HG
Daust, HA
Carritte, A
Douville, CC
Goedegebuure, PS
Eberlein, TJ
Citation: Dc. Lockhart et al., Loss of T-cell receptor-CD3 zeta and T-cell function in tumor-infiltratinglymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma, SURGERY, 129(6), 2001, pp. 749-756
Citation: Y. Tanaka et al., Modification of the HER2/neu-derived tumor antigen GP2 improves induction of GP2-reactive cytotoxic T lymphocytes, INT J CANC, 94(4), 2001, pp. 540-544
Authors:
Chan, AK
Goedegebuure, PS
von Bernstorff, W
Carritte, AL
Chung, M
Stewart, RA
Montgomery, L
Spanjaard, RA
McKenzie, AB
Eberlein, TJ
Citation: Ak. Chan et al., B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor, SURGERY, 127(3), 2000, pp. 342-350
Authors:
Eberlein, TJ
Gaber, AO
Pinson, CW
Fong, Y
Citation: Tj. Eberlein et al., Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model - Discussion, ANN SURG, 231(5), 2000, pp. 769-771
Authors:
Sadanaga, N
Nagoshi, M
Lederer, JA
Joo, HG
Eberlein, TJ
Goedegebuure, PS
Citation: N. Sadanaga et al., Local secretion of IFN-gamma induces an antitumor response: Comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells, J IMMUNOTH, 22(4), 1999, pp. 315-323
Authors:
Peiper, M
Langwieler, TE
Knoefel, WT
Goedegebuure, PS
Eberlein, TJ
Izbicki, JR
Citation: M. Peiper et al., Comparison of several antigen-presenting cells for generation of tumor-peptide specific cytotoxic T lymphocytes in pancreatic cancer, LANG ARCH S, 1999, pp. 303-306
Authors:
Matory, YL
Dorfman, DM
Wu, L
Chen, M
Goedegebuure, P
Eberlein, TJ
Citation: Yl. Matory et al., Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfectedmouse mammary tumor, PATHOBIOLOG, 67(4), 1999, pp. 186-195
Authors:
Matory, YL
Dorfman, DM
Chen, M
Wu, L
Spanjaard, RA
Goedegebuure, PS
Eberlein, TJ
Citation: Yl. Matory et al., T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor, PATHOBIOLOG, 67(1), 1999, pp. 3-11
Authors:
Peiper, M
Goedegebuure, PS
Izbicki, JR
Eberlein, TJ
Citation: M. Peiper et al., Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu, ANTICANC R, 19(4A), 1999, pp. 2471-2475
Authors:
von Bernstorff, W
Spanjaard, RA
Chan, AK
Lockhart, DC
Sadanaga, N
Wood, I
Peiper, M
Goedegebuure, PS
Eberlein, TJ
Citation: W. Von Bernstorff et al., Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand, SURGERY, 125(1), 1999, pp. 73-84
Authors:
Chan, AK
Lockhart, DC
von Bernstorff, W
Spanjaard, RA
Joo, HG
Eberlein, TJ
Goedegebuure, PS
Citation: Ak. Chan et al., Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T-cell activation, INT J CANC, 82(5), 1999, pp. 721-726
Authors:
Nagoshi, M
Sadanaga, N
Joo, HG
Goedegebuure, PS
Eberlein, TJ
Citation: M. Nagoshi et al., Tumor-specific cytokine release by donor T cells induces an effective hostanti-tumor response through recruitment of host naive antigen presenting cells, INT J CANC, 80(2), 1999, pp. 308-314